On Sputnik V For India, Price Issues – AstraZeneca Price Too Low, Says Maker

Despite India’s drug regulator DCGI (Drugs Controller General of India) clearing the Russian Sputnik V vaccine for use in the country, there is still no decision on the price at which the vaccine…

Leave a Reply

Your email address will not be published. Required fields are marked *

error: Content is protected !!